Literature DB >> 1815782

Semiautomated T-bag peptide synthesis using 9-fluorenyl-methoxycarbonyl strategy and benzotriazol-1-yl-tetramethyl-uronium tetrafluoroborate activation.

A G Beck-Sickinger1, H Dürr, G Jung.   

Abstract

Multiple peptide synthesis using the T-bag method is considerably facilitated using 9-fluorenyl-methoxycarbonyl strategy and benzotriazol-1-yl-tetramethyl-uronium tetrafluoroborate activation. Convenient protocols were achieved when semiautomation was applied. Successful syntheses of analogues of neuropeptide Y demonstrate the advantages of these improvements. Various peptides consisting of up to eighteen residues were built up with unusual amino acid residues. Useful hints are given for semiautomated multiple peptide synthesis for up to 120 different peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1815782

Source DB:  PubMed          Journal:  Pept Res        ISSN: 1040-5704


  5 in total

1.  Synthesis of a novel lipopeptide with alpha-melanocyte-stimulating hormone peptide ligand and its effect on liposome stability.

Authors:  Y Ogawa; H Kawahara; N Yagi; M Kodaka; T Tomohiro; T Okada; T Konakahara; H Okuno
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

2.  Peptidyl molecular imaging contrast agents using a new solid-phase peptide synthesis approach.

Authors:  Byunghee Yoo; Mark D Pagel
Journal:  Bioconjug Chem       Date:  2007-03-02       Impact factor: 4.774

3.  Synthetic histatin analogues with broad-spectrum antimicrobial activity.

Authors:  E J Helmerhorst; W Van't Hof; E C Veerman; I Simoons-Smit; A V Nieuw Amerongen
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

4.  Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.

Authors:  L J Cross; A G Beck-Sickinger; M Bienert; W Gaida; G Jung; E Krause; M Ennis
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

5.  Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.

Authors:  H Siakkou; S Jahn; N Kienzle; R Ulrich; C Grötzinger; T Schneider; B Kohleisen; G Pauli; R Spohn; G Jung
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.